SBIR Innovative Concept Award - Detection, Diagnosis, Treatment, Prevention and Research of Pediatric Cancers and/or Rare Cancers.

SBIR 创新概念奖 - 儿童癌症和/或罕见癌症的检测、诊断、治疗、预防和研究。

• 批准号: 10553585
• 负责人: Melvin Piestrup
• 金额: $ 30万
• 依托单位: ADELPHI TECHNOLOGY, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-20 至 2023-01-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10553585
• 关键词: Anatomy; Award; Boron; Boron Neutron Capture Therapy; Cancerous; Cell Death; Cells; Collimator; Detection; Diagnosis; Diffuse intrinsic pontine glioma; Dimensions; Dose; Drug Delivery Systems; Fast Neutrons; Malignant Childhood Neoplasm; Malignant Neoplasms; Methods; Neutrons; Optics; Organ; Palliative Care; Patients; Pontine structure; Prevention Research; Radiation; Radiation therapy; Shapes; Small Business Innovation Research Grant; Source; Tissues; Tumor Volume; base; cancer cell; innovation; minimally invasive; rare cancer; tumor growth

A compact neutron source with collimator and drug delivery method will be developed that permits radiation to go directly to the cancerous cells of the pons, while minimizing the dose to healthy tissue and organs. In conventional radiation therapy, the main palliative treatment for Diffuse Intrinsic Pontine Glioma, both healthy and cancerous cells receive roughly the same dose. This temporarily slows the tumor growth, but radiation treatments must be discontinued to limit healthy tissue damage. Boron Neutron Capture Therapy (BNCT) is a radiation treatment that can provide a more targeted destruction of the cancer cells while minimizing healthy tissue damage. A new compact neutron generator married to a neutron optic can deliver the neutrons directly to the pons and, with a precise boron delivery, result in specific cancer cell destruction. To provide a more directional tumor-volume and cell-specific targeting we propose a compact neutron generator integrated with a spectral- and volume-shaping delivery optic to direct thermal neutrons to the pons inside the body with minimal invasiveness. The ratio of the boron delivered to the cancer cells vs that taken up by healthy cells increases the cancer cell death by roughly the same ratio, permitting increased dose to the cancer.

将开发一种带有准直器和药物输送方法的紧凑型中子源，允许辐射直接到达脑桥的癌细胞，同时最大限度地减少对健康组织和器官的剂量。 在传统的放射治疗中，弥漫性内在脑桥胶质瘤的主要姑息治疗，健康细胞和癌细胞接受大致相同的剂量。 这暂时减缓了肿瘤的生长，但必须停止放射治疗以限制健康组织的损伤。硼中子捕获疗法（BNCT）是一种放射治疗，可以更有针对性地破坏癌细胞，同时最大限度地减少健康组织的损伤。一种新的紧凑型中子发生器与中子光学器件结合，可以将中子直接输送到脑桥，并通过精确的硼输送，导致特定的癌细胞破坏。为了提供更定向的肿瘤体积和细胞特异性靶向，我们提出了一种紧凑的中子发生器，其与光谱和体积成形递送光学器件集成，以最小的侵入性将热中子引导到体内的脑桥。递送到癌细胞的硼与健康细胞吸收的硼的比率以大致相同的比率增加癌细胞死亡，从而允许增加癌症的剂量。